The purpose of this legislation, known as the PBM Reporting Transparency Act, is to enhance transparency regarding the agreements between pharmacy benefit managers (PBMs) and Medicare prescription drug plans. The goal is to provide Congress with detailed insights into how these agreements affect costs for consumers and the overall healthcare system. The key provisions of the Act require the Medicare Payment Advisory Commission (MedPAC) to produce two reports for Congress.